Five Star Equities Provides Stock Research on Impax Laboratories and Spectrum Pharmaceuticals
Continue ReadingTag: equity-research
Machinery Industry Looks to Benefit as Companies Can Write Off Up to $500k in New Asset Purchases Under Fiscal Cliff Deal
The Paragon Report Provides Stock Research on Deere & Company and Titan Machinery
Continue Reading
Fiscal Cliff Legislation Extends Alternative Fuels Tax Credits Through 2013
Five Star Equities Provides Stock Research on Archer Daniels Midland and Pacific Ethanol
Continue Reading
Chinese Solar Demand Expected to Grow as China-s Pushes Urbanization Plans
The Paragon Report Provides Stock Research on Canadian Solar and JA Solar
Continue Reading
Gold Posts 12th Consecutive Year of Gains With a 6% Increase in 2012
The Paragon Report Provides Stock Research on Goldcorp and IAMGOLD
Continue Reading
Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry-s Success in 2012
Five Star Equities Provides Stock Research on Navidea Biopharmaceuticals and NuPathe
Continue Reading
Machinery Industry on the Upswing as Orders for Capital Goods Show Back-to-Back Monthly Increases
The Paragon Report Provides Stock Research on Manitowoc and Terex
Continue Reading
Amyris and Solazyme Shares Surge as Alternative Fuels Tax Credit Extended Through 2013
Five Star Equities Provides Stock Research on Amyris and Solazyme
Continue Reading
Chinese Solar Stocks on an Impressive Run to Start the Year After a Dismal 2012
The Paragon Report Provides Stock Research on LDK Solar and Trina Solar
Continue Reading
Renewable Energy and Alternative Fuels Stocks Rally as Deal to Avoid “Fiscal Cliff” Extends Industry Tax Credits
Five Star Equities Provides Stock Research on Renewable Energy Group and Gevo
Continue Reading